| __timestamp | Merus N.V. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 3852327 | 381287000 |
| Thursday, January 1, 2015 | 839656 | 452612000 |
| Friday, January 1, 2016 | 4478145 | 316800000 |
| Sunday, January 1, 2017 | 16432324 | 330100000 |
| Monday, January 1, 2018 | 11890871 | 265800000 |
| Tuesday, January 1, 2019 | 34110000 | 336200000 |
| Wednesday, January 1, 2020 | 35781000 | 423900000 |
| Friday, January 1, 2021 | 40896000 | 467000000 |
| Saturday, January 1, 2022 | 52200000 | 487000000 |
| Sunday, January 1, 2023 | 59836000 | 477100000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Merus N.V. from 2014 to 2023. Over this period, United Therapeutics consistently outspent Merus N.V., with SG&A expenses peaking at approximately $487 million in 2022, a 26% increase from 2014. In contrast, Merus N.V. showed a more dynamic growth, with expenses surging from under $1 million in 2015 to nearly $60 million in 2023, marking a staggering 7000% increase. This stark contrast highlights differing operational scales and strategic priorities. While United Therapeutics maintains a steady financial commitment to its operations, Merus N.V.'s rapid increase suggests aggressive expansion and investment in its growth trajectory.
Johnson & Johnson or Merus N.V.: Who Manages SG&A Costs Better?
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Incyte Corporation and Merus N.V.
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Merus N.V. Trends and Insights
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends